Unaudited financial results for the quarter ended on June 30, 2025 is attached here
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories reported Q1 FY26 revenue from operations of ₹1,813.54 lakhs, up about 8.7% from ₹1,667.66 lakhs in the same quarter last year. Profit after tax nearly tripled to ₹96.76 lakhs versus ₹34.15 lakhs in Q1 FY25, driven by lower other expenses and favourable inventory changes. Earnings per share rose sharply to ₹8.06 from ₹2.85 a year earlier. EBITDA margin expanded meaningfully, from roughly 10.5% to nearly 14%, showing better cost efficiency. The statutory auditor issued an unqualified limited review report with no qualifications or emphasis-of-matter notes.
A strong quarter for shareholders — profit growth far outpaced revenue growth, signalling improving margins and operational leverage. This is a positive earnings signal, though the company remains small and the stock may see only a modest reaction.